The Fruit of Knowledge
Health & Science
UPDATE 1-New ‘Obamacare’ exchanges could miss enrollment deadline -GAO
Jun 19th
June 19 (Reuters) – New health insurance exchanges being set up by the federal government in more than 30 states under President Barack Obama’s 2010 healthcare overhaul could miss an Oct. 1 deadline for open enrollment, a government report said on Wednesday.
Denmark’s Novo Nordisk says S&P lifts its credit rating
Jun 19th
COPENHAGEN, June 19 (Reuters) – Denmark’s Novo Nordisk , the world’s biggest insulin producer, has had its long-term corporate credit rating raised by Standard & Poor’s to “AA-” from “A+”, with a stable outlook, the company said.
Cervical cancer vaccines cut rates of HPV infections -U.S.
Jun 19th
CHICAGO, June 19 (Reuters) – The U.S. introduction of a vaccine to prevent cervical cancer in 2006 has reduced infections with the human papillomavirus or HPV – the sexually transmitted virus that causes the disease – by more than half among girls and young women, U.S. health officials said on Wednesday.
Cervical cancer vaccines cut rates of HPV infections: U.S
Jun 19th
CHICAGO (Reuters) – The U.S. introduction of a vaccine to prevent cervical cancer in 2006 has reduced infections with the human papillomavirus or HPV – the sexually transmitted virus that causes the disease – by more than half among girls and young women, U.S. health officials said on Wednesday.
Afghan leader balks at Taliban talks
Jun 19th
Hamid Karzai won't pursue talks unless the U.S. steps out of negotiations.
The Love That Dared Not Speak Its Name, Of A Beetle For A Beer Bottle
Jun 19th
What’s that beetle doing to that beer bottle? The beetle dropped down from the sky, grabbed the bottle’s bottom, keeps hugging and hugging it, even when being attacked by ants, and it won’t — refuses to — let go. It can’t be the beer it’s after. The beer is at the other end. What’s going on?
What really caused TWA Flight 800 crash?
Jun 19th
UPDATE 2-Astra, Bristol diabetes drug disappoints in key test
Jun 19th
LONDON, June 19 (Reuters) – AstraZeneca and Bristol-Myers Squibb’s diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might demonstrate an edge over rivals.
CORRECTED-UPDATE 1-Niche drugmaker ViroPharma attracts takeover interest – sources
Jun 19th
(In June 17 item, corrects in 3rd paragraph to show that ViroPharma is 19 years old)
Niche drugmaker ViroPharma attracts takeover interest: sources
Jun 19th
NEW YORK (Reuters) – ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquisition interest from several pharmaceutical companies, according to three people familiar with the matter.
